Literature DB >> 19389948

Impact of postpartum milking frequency on the immune system and the blood metabolite concentration of dairy cows.

M C Loiselle1, C Ster, B G Talbot, X Zhao, G F Wagner, Y R Boisclair, P Lacasse.   

Abstract

The transition from pregnancy to lactation is marked by metabolic, hormonal, and immunological changes that have an impact on the incidence of infectious and metabolic diseases. The aim of this study was to evaluate the effect on immune function and blood metabolite concentration of limiting milk production in early lactation to reduce negative energy balance. Twenty-two multiparous Holstein cows were milked either once a day (1x) or twice a day (2x) for the first week postpartum. All cows were milked twice daily for the rest of lactation. Blood concentrations of nonesterified fatty acids (NEFA), beta-hydroxybutyric acid (BHBA), calcium, bilirubin, urea, phosphorus, glucose, leptin, stanniocalcin-1, and 17beta-estradiol were determined in samples collected from 5 wk before scheduled calving to 5 wk after calving. Polymorphonuclear leukocytes (PMNL) were isolated from blood to conduct assays for chemotaxis, phagocytosis, and respiratory burst. Peripheral blood mononuclear cells (PBMC) were isolated to evaluate lymphocyte proliferation and cytokine production (tumor necrosis factor-alpha, IL-4, and interferon-gamma). Cows milked 1x produced 31% less milk than cows milked 2x during the first week of lactation. Over the following 13 wk of lactation, the milk production of cows milked 1x during the first week was 8.1% lower than for cows milked 2x. However, because the percentages of fat and protein were greater in the milk from 1x cows, the yields of milk components and energy-corrected milk were similar. Calving induced an increase in the concentrations of NEFA, BHBA, urea, and bilirubin. The increases in levels of NEFA and BHBA were greater in cows milked 2x than in cows milked 1x. During the same period, the serum glucose concentration decreased but remained greater in cows milked 1x. Serum calcium on d 4 and serum phosphorus on d 4 and 5 were greater in cows milked 1x. The differences between the 2 groups persisted beyond treatment until postpartum d 24 for NEFA and glucose and until postpartum d 14 for BHBA. After calving, the concentrations of leptin and stanniocalcin-1 decreased. During the first week postpartum, the decrease of leptin was less marked in cows milked 1x. The immune functions of PBMC and PMNL isolated from experimental cows and incubated using a standard medium did not show clear-cut peripartum immunosuppression. These variables were not significantly affected by the treatments, with the exception of interferon-gamma secretion, which was greater on d 5 and 14 in cows milked 1x. In conclusion, limiting milk production in early lactation had positive effects on metabolite concentration, but larger studies are necessary to establish if this could reduce disease incidence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389948     DOI: 10.3168/jds.2008-1399

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  10 in total

1.  Changes in leukocyte populations of cows with milk fever or displaced abomasum after calving.

Authors:  Hiromichi Ohtsuka; Shigeo Fukuda; Katsunori Kudo; Michiko Tomioka; Masateru Koiwa; Kayoko Kimura
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

2.  Supplementation strategies for Nellore female calves in creep feeding to improve the performance: nutritional and metabolic responses.

Authors:  Daniel Mageste de Almeida; Marcos Inácio Marcondes; Luciana Navajas Rennó; Leandro Soares Martins; David Esteban Contreras Marquez; Faider Castaño Villadiego; Felipe Velez Saldarriaga; Román Maza Ortega; Deilen Paff Sotelo Moreno; Sidnei Antônio Lopes; Manuela Acevedo Cardozo; Mário Fonseca Paulino
Journal:  Trop Anim Health Prod       Date:  2018-05-21       Impact factor: 1.559

Review 3.  Nutrigenomic Interventions to Address Metabolic Stress and Related Disorders in Transition Cows.

Authors:  Faiz-Ul Hassan; Asif Nadeem; Maryam Javed; Muhammad Saif-Ur-Rehman; Muhammad Aasif Shahzad; Jahanzaib Azhar; Borhan Shokrollahi
Journal:  Biomed Res Int       Date:  2022-06-11       Impact factor: 3.246

Review 4.  Metabolic Disorders in the Transition Period Indicate that the Dairy Cows' Ability to Adapt is Overstressed.

Authors:  Albert Sundrum
Journal:  Animals (Basel)       Date:  2015-10-09       Impact factor: 2.752

Review 5.  A review on nanosystems as an effective approach against infections of Staphylococcus aureus.

Authors:  Kaixiang Zhou; Chao Li; Dongmei Chen; Yuanhu Pan; Yanfei Tao; Wei Qu; Zhenli Liu; Xiaofang Wang; Shuyu Xie
Journal:  Int J Nanomedicine       Date:  2018-11-09

6.  Enhanced Treatment Effects of Tilmicosin Against Staphylococcus aureus Cow Mastitis by Self-Assembly Sodium Alginate-Chitosan Nanogel.

Authors:  Kaixiang Zhou; Xiaofang Wang; Dongmei Chen; Yuanyuan Yuan; Shuge Wang; Chao Li; Yuanyuan Yan; Qianying Liu; Liwei Shao; Lingli Huang; Zonghui Yuan; Shuyu Xie
Journal:  Pharmaceutics       Date:  2019-10-12       Impact factor: 6.321

7.  The Autumn Low Milk Yield Syndrome in High Genetic Merit Dairy Cattle: The Possible Role of a Dysregulated Innate Immune Response.

Authors:  Massimo Amadori; Chiara Spelta
Journal:  Animals (Basel)       Date:  2021-02-03       Impact factor: 2.752

8.  Relationship between Postpartum Metabolic Status and Subclinical Endometritis in Dairy Cattle.

Authors:  Uxía Yáñez; Pedro G Herradón; Juan J Becerra; Ana I Peña; Luis A Quintela
Journal:  Animals (Basel)       Date:  2022-01-20       Impact factor: 2.752

9.  Thymol Disrupts Cell Homeostasis and Inhibits the Growth of Staphylococcus aureus.

Authors:  Qingxiang Li; Ke Xing Huang; Sheng Pan; Chun Su; Juan Bi; Xuan Lu
Journal:  Contrast Media Mol Imaging       Date:  2022-08-13       Impact factor: 3.009

10.  Targeting therapy effects of composite hyaluronic acid/chitosan nanosystems containing inclusion complexes.

Authors:  Zhiwei Liang; Dongmei Chen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.